Prognostic Value of CD133 and SOX2 in Advanced Cancer.

J Oncol · 2019 · PMC6332999 · PMID 30693028

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendP = 0.057so close (0.05 < p ≤ 0.1)

We found that patients with CD133-positive advanced cancer was correlated with poorer CSS (HR = 3.70, P = 0.036) and showed a trend towards poor OS (HR = 1.57, P = 0.057), but no relationship was reported between CD133 positivity and DFS (HR = 1.62, P = 0.178).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.